- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
UPDATED Apr 24, 2024
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
29 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ROG | CHF222.20 | 1.0% | -19.1% | CHF179.0b | CHF281.06 | PE15.4x | E8.2% | 4.3% | ||
MEDP | US$397.56 | 4.0% | 94.9% | US$12.6b | US$425.47 | PE39.4x | E13.0% | n/a | ||
BRKR | US$82.20 | -0.9% | 6.1% | US$12.0b | US$89.40 | PE28x | E2.5% | 0.2% | ||
500488 | ₹25,663.50 | -1.5% | 15.9% | ₹541.1b | ₹27,670.43 | PE47.6x | E13.2% | 1.3% | ||
9926 | HK$48.45 | 6.7% | 12.4% | HK$41.1b | HK$59.75 | PE19.1x | E12.2% | n/a | ||
ROVI | €79.60 | -1.4% | 96.5% | €4.1b | €79.18 | PE24.2x | E15.2% | 1.4% | ||
500660 | ₹2,065.40 | 9.3% | 65.9% | ₹352.3b | ₹2,141.25 | PE66.2x | E21.1% | 1.5% | ||
ALKS | US$24.65 | 2.7% | -13.1% | US$4.1b | US$35.25 | PE8x | E-15.5% | n/a | ||
BONEX | kr243.60 | 2.3% | 165.5% | kr16.0b | kr292.67 | PE65.3x | E23.6% | n/a | ||
6600 | HK$17.98 | -0.3% | 54.5% | HK$11.0b | HK$17.86 | PE9x | E4.7% | 0% | ||
MDXG | US$6.43 | 1.6% | 81.1% | US$960.8m | US$12.44 | PE17x | E15.0% | n/a | ||
SIGA | US$8.66 | 1.8% | 57.7% | US$622.8m | n/a | PE9x | S8.8% | 6.9% | ||
6785 | NT$298.50 | -2.8% | 92.6% | NT$19.9b | n/a | PE52.1x | n/a | 0.5% | ||
AHEALTH | RM3.20 | 6.7% | 20.6% | RM2.2b | RM2.64 | PE5.8x | E-50.3% | 7.8% | ||
DEVA | ₺72.80 | 2.0% | 86.1% | ₺14.6b | n/a | PE6.3x | n/a | 0.2% | ||
4728 | NT$224.50 | -1.5% | -18.4% | NT$12.2b | n/a | PE19.5x | n/a | 4.2% | ||
506879 | ₹404.70 | 5.7% | 169.3% | ₹29.7b | n/a | PE53.5x | n/a | 0.3% | ||
A290650 | ₩20,500.00 | 1.0% | -33.2% | ₩465.0b | n/a | PE9.6x | n/a | 0.5% | ||
HVO | UK£0.28 | 3.3% | 66.2% | UK£193.9m | n/a | PE12x | E-12.1% | 0.7% | ||
GENO | kr26.90 | -5.6% | -51.9% | kr1.8b | kr50.50 | PE28.6x | E-13.9% | n/a | ||
ELTP | US$0.13 | -7.0% | 298.4% | US$131.6m | n/a | PE8.7x | n/a | n/a | ||
6817 | NT$129.00 | -1.1% | 65.4% | NT$2.4b | n/a | PE15x | n/a | 5.1% | ||
MAB | zł16.64 | -5.5% | -7.8% | zł268.9m | zł16.17 | PE6.5x | E-103.2% | n/a | ||
524632 | ₹91.60 | 10.2% | 299.3% | ₹3.9b | n/a | PE21.6x | n/a | 0.1% |